Browsing: Novo Nordisk
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
GLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere. In recent years, this class of weight-loss and Type 2 diabetes…
Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds
Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Zepbound (tirzepatide), manufactured…
Novo Nordisk Foundation CEO dismisses ‘Nokia risk’ as ‘fundamentally different’ for Denmark’s economy
The CEO of the Novo Nordisk Foundation (NNF), the philanthropic arm of the Danish Ozempic-making pharmaceutical giant, says Denmark is…
Initial prescriptions for the drug are expected to be issued in Shanghai this week, Yicai news service reported Monday. Wegovy…
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
In June, the Supreme Court overturned the decades-old Chevron doctrine that empowered a federal agency’s “reasonable interpretation of ambiguous federal…
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss medicine tirzepatide. Susan McGowan, 58, died from…
Danish town where weight-loss wonderdrug Ozempic is made suffers from the highest rates of overweight children in Denmark
Novo Nordisk has become Europe’s most valuable company due to soaring demand for its weight loss-aiding drugs Wegovy, Semaglutide, and…
Novo Nordisk A/S was cited for quality lapses at a drug production plant in Denmark that makes the hit medicines…
Less than a year ago, the head of Novo Nordisk A/S was fielding calls from “scared” food industry executives about his company’s…
People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to…